Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.

Human immunodeficiency virus type 1 (HIV-1) isolates resistant to zidovudine (ZDV) have previously been demonstrated to exhibit in vitro cross-resistance to other similar dideoxynucleoside agents which contain a 3'-azido group. However, cross-resistance to didanosine (ddI) or dideoxycytidine (ddC) h...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Mayers, D L, Japour, A J, Arduino, J M, Hammer, S M, Reichman, R, Wagner, K F, Chung, R, Lane, J, Crumpacker, C S, McLeod, G X
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1994
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284445/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8192457/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.2.307
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!